Butkiewicz N J, Wendel M, Zhang R, Jubin R, Pichardo J, Smith E B, Hart A M, Ingram R, Durkin J, Mui P W, Murray M G, Ramanathan L, Dasmahapatra B
Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA.
Virology. 1996 Nov 15;225(2):328-38. doi: 10.1006/viro.1996.0607.
The NS3 proteinase of hepatitis C virus utilizes NS4A as a cofactor for cleavages at four sites (3/4A, 4A/4B, 4B/5A, and 5A/5B) in the nonstructural region of the viral polyprotein. To characterize NS4A for its role in modulating the NS3 proteinase activity at various cleavage sites, synthetic peptides spanning various parts of NS4A were synthesized and tested in a cell-free trans-cleavage reaction using purified NS3 proteinase domain and polyprotein substrates. The NS3 proteinase domain was expressed in Escherichia coli, purified, denatured, and refolded to an enzymatically active form. We found that a 12-amino-acid peptide containing amino acid residues 22 to 33 in NS4A (CVVIVGRIVLSG) was sufficient for cofactor activity in NS3-mediated proteolysis. The peptide enhanced the cleavage at the NS5A/5B site and was necessary for NS3-mediated cleavage at NS4A/4B and NS4B/5A. Sequential amino acid substitution within the designated peptide identified residues I29 and I25 as critical for potential cofactor activity. We provide evidence that the NS4A peptide and the NS3 catalytic domain form an enzymatically active complex. These data suggest that the central 12-amino-acid peptide (aa 22-33) of NS4A is primarily important for the cofactor activity through complex formation with NS3, and the interaction may represent a new target for antiviral drug development.
丙型肝炎病毒的NS3蛋白酶利用NS4A作为辅助因子,在病毒多聚蛋白的非结构区域的四个位点(3/4A、4A/4B、4B/5A和5A/5B)进行切割。为了表征NS4A在调节NS3蛋白酶在不同切割位点的活性中的作用,合成了跨越NS4A各个部分的合成肽,并使用纯化的NS3蛋白酶结构域和多聚蛋白底物在无细胞转切割反应中进行了测试。NS3蛋白酶结构域在大肠杆菌中表达、纯化、变性并重新折叠成具有酶活性的形式。我们发现,NS4A中包含氨基酸残基22至33的12个氨基酸的肽(CVVIVGRIVLSG)足以在NS3介导的蛋白水解中发挥辅助因子活性。该肽增强了NS5A/5B位点的切割,并且是NS3介导的NS4A/4B和NS4B/5A切割所必需的。在指定肽内进行的连续氨基酸取代确定残基I29和I25对潜在的辅助因子活性至关重要。我们提供的证据表明,NS4A肽和NS3催化结构域形成了具有酶活性的复合物。这些数据表明,NS4A的中央12个氨基酸的肽(第22 - 33位氨基酸)通过与NS3形成复合物,对辅助因子活性至关重要,并且这种相互作用可能代表了抗病毒药物开发的新靶点。